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While it is clear that some amphibian populations have recently experienced precipitous declines, the causes of those
die-offs are complex and likely involve multiple variables. One theory suggests that environmental factors may trigger events
that result in depressed immune function and increased susceptibility to infectious disease. Here we examine one aspect of
innate immunity in amphibians and show that esculentin-2P (E2P) and ranatuerin-2P (R2P), two antimicrobial peptides
isolated from Rana pipiens, inactivate frog virus 3, a potentially pathogenic iridovirus infecting anurans, and channel catfish
herpesvirus. In contrast to mammalian antimicrobial peptides, E2P and R2P act within minutes, at temperatures as low as
0°C, to inhibit viral infectivity. Moreover, these compounds appear to inactivate the virus directly and do not act by inhibiting
replication in infected cells. This is the first report linking amphibian antimicrobial peptides with protection from an amphibian
viral pathogen and suggests that these compounds may play a role in maintaining amphibian health. © 2001 Academic Press
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There are over 100 known antimicrobial peptides
(AMPs) synthesized by vertebrates (Lehrer et al., 1993;
Nicolas and Mor, 1995; Boman, 1995; Simmaco et al.,
1998). A variety of structurally diverse AMPs are present
in the skin secretions of several amphibian and fish
species (Goraya et al., 1998, 2000; Simmaco et al., 1993).
mong these, esculentin-2P (E2P) and ranatuerin-2P
R2P), recently isolated from Rana pipiens, were shown
o inhibit the growth of gram-positive (Staphylococcus
ureus) and gram-negative (Escherichia coli) bacteria as
ell as Candida albicans (Goraya et al., 2000). In mam-
als, AMPs are found in neutrophils and macrophages
e.g., defensins) and within glands lining the digestive
nd respiratory tract. Similar to the presumed function of
2P and R2P, mammalian AMPs are thought to function
s a first line of defense against pathogenic micro-
rganisms (Lehrer et al., 1993; Nicolas and Mor, 1995).
Collectively, AMPs are small (20–46 amino acids), ba-
ic (i.e., lysine- and arginine-rich), amphipathic peptides
hat can be classified by structural features into at least
our distinct families. (a) The defensin-like family of
MPs is distinguished by three intramolecular disulfide
onds that maintain the peptide as a rigid, triple-
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology, University of Mississippi Med-I
s
cal Center, 2500 N. State Street, Jackson, MS 39211. Fax: (601) 984-
708. E-mail: vchinchar@microbio.umsmed.edu.
351tranded, b sheet. (b) A second family (Bac-5, Bac-7, and
R-39) lacks disulfide bonds but is exceptionally proline/
rginine-rich, with these amino acids making up more
han 60% of residues. (c) The magainin-like family (bom-
inins, magainins, and dermaseptins) contains linear,
mphipathic, helical peptides lacking disulfide bonds. (d)
fourth family, encompassing brevinins, esculentins,
anatuerins, and ranalexin, differs from defensin-like
eptides in possessing a single disulfide bond involving
losely spaced cysteines at the C-terminus of the pep-
ide (Table 1). Although the inhibitory mechanism of
MPs is not completely understood, all four families are
hought to function by forming pores within microbial
embranes and disrupting essential metabolic func-
ions. However, despite their presumed common lytic
echanism, the antimicrobial spectrum of these com-
ounds varies widely. Some agents (e.g., mammalian
efensins) show activity against multiple bacterial, fun-
al, and viral species, whereas others (e.g., bombins)
nhibit only a limited number of pathogens (Lehrer et al.,
993; Nicolas and Mor, 1995). Surprisingly, even struc-
urally related homologous peptides differ markedly in
heir activity toward a given pathogen (Lehrer et al., 1985;
oraya et al., 2000).
In this report, the ability of E2P and R2P to inactivate
wo viruses, the iridovirus, frog virus 3 (FV3), and the
erpesvirus, channel catfish virus (CCV), was investi-
ated. FV3 was chosen as a representative of the familyridoviridae, which has recently been linked to wide-
pread die-offs of frogs and salamanders (Cunningham
0042-6822/01 $35.00
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352 CHINCHAR ET AL.et al., 1996; Jancovich et al., 1997; Bollinger et al., 1999;
aszak et al., 1999; Zhang et al., in press). CCV was
hosen because this herpesvirus also infects only cold-
looded animals and, unlike FV3, is absolutely depen-
ent upon its membrane for infectivity (Abodeely et al.,
970; Roizman and Furlong, 1974; Davison, 1992; Booy et
l., 1996). Previously we examined the ability of six pep-
ides (dermaseptin, ranalexin, magainin-I and -II, CPF,
nd PGLa) from three amphibian species to block the
eplication of fungal (Batrachochytrium dendrobatidis
nd Basidiobolus ranarum) and bacterial (Aeromonas
ydrophila) agents associated with amphibian disease
Rollins-Smith et al., in press). Here we show that two
ther AMPs, E2P and R2P, markedly inhibited FV3 and
CV plaque formation (i.e., infectivity) at concentrations
anging from 5 to 500 mM. Furthermore, we provide
evidence that the peptides directly inactivated virus
rather than blocking replication in virus-infected cells.
This is the first report demonstrating that amphibian
AMPs inhibit the replication of viruses pathogenic to
cold-blooded vertebrates and suggests that these pep-
tides may play a role in protecting amphibians from viral
disease.
RESULTS
Effect of E2P and R2P on FV3 and CCV infectivity
To determine whether one or both of the amphibian
skin-derived peptides possessed antiviral activity, FV3
and CCV were incubated in the presence of various
concentrations of E2P or R2P for 1 h at 26°C. After 1 h the
samples were diluted 100-fold and the residual infectivity
was measured by plaque assay. FV3 was chosen as a
test virus because it is the type species of the genus
Ranavirus (family Iridoviridae) (Willis et al., 1985; Williams
et al., 2000). Several members of this genus have been
implicated in die-offs of amphibians and fish (Daszak et
al., 1999). However, because FV3 preparations are mix-
tures of enveloped and nonenveloped virions, both of
which are infectious (Braunwald et al., 1979), and be-
cause amphibian skin peptides such as E2P and R2P are
thought to act by disrupting membranes rather than by
altering protein–protein interactions (i.e., viral capsids),
TABLE 1
Primary Structure of E2P and R2P
Esculentin-2P
GFS SIF RGV AKF ASK GLG KDL ARL GVN LVA CKI SKQ C
Ranatuerin-2P
GLM DTV KNV AKN LAG HML DKL KCK ITG C
Note. Basic amino acid residues are in boldface type. Cysteine
esidues involved in disulfide bond formation are in italics.we also tested the effect of these compounds on CCV, a
fish pathogen that requires a viral envelope for infectivity.As shown in Fig. 1, treatment of both FV3 and CCV with
E2P or R2P at concentrations ranging from 5 to 500 mM
esulted in a marked reduction in infectivity as judged by
laque assay. CCV plaque formation was inhibited by
99% at E2P and R2P concentrations as low as 50 mM,
whereas FV3 titers were inhibited by .90% at 500 mM
E2P or R2P. This level of inhibition was roughly equiva-
lent to that achieved by mammalian AMPs when tested
against a panel of enveloped viruses (Lehrer et al., 1985;
Daher et al., 1986; Yasin et al., 2000). Consistent with the
ossibility that E2P and R2P are targeted to membranes,
CV was greater than 10-fold more sensitive to these
ompounds than FV3. Finally, preliminary evidence indi-
ated that 500 mM E2P or R2P reduced the infectivity of
egina ranavirus, an iridovirus linked to widespread die-
ffs among tiger salamanders in western North America
Bollinger et al., 1999), by ;90% (data not shown).
Several additional features of these compounds de-
serve comment. (a) In keeping with their assignment to
the same peptide family, the inhibitory activities of E2P
and R2P were found to be additive, rather than synergis-
FIG. 1. Effect of E2P and R2P on FV3 and CCV Infectivity. Ten-
microliter aliquots of FV3 (top) or CCV (bottom) were mixed with an
equal volume of peptide or water at the indicated concentrations and
incubated for 1 h at 26°C. Subsequently, the virus titer was determined
by plaque assay and expressed as percentage of control. The data
represent the mean of three to seven repetitions; error bars indicate 1
standard deviation.
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353ANTIMICROBIAL PEPTIDES ISOLATED FROM FROG SKINtic (data not shown). (b) Because some AMPs have
cytolytic as well as an antimicrobial activity, the integrity
of fathead minnow (FHM) and channel catfish ovary
(CCO) cells was visually monitored after exposure to E2P
and R2P. We found that neither FHM nor CCO cell mono-
layers were lysed by peptide concentrations as high as
10 mM, indicating that at inhibitory concentrations E2P
nd R2P were not cytolytic (data not shown). (c) To rule
ut that possibility that a random peptide might possess
ntimicrobial activity, we tested the inhibitory ability of
wo MAP peptides {aMAP2, [(TNGTWPTNEYKEDA)2 K]2
KA and bMAP, [(KLTIDEDNYETYV)2 K]2 KA} that contain
epitopes for catfish T cell receptor a and b chains (Pos-
nett et al., 1988). At a concentration of 75 mM, aMAP2
nd bMAP lowered the CCV titer to ;60% of control. In
ontrast, 50 mM E2P reduced the titer of CCV to 0.2% of
he control value. (d) Finally, to determine whether virus
hat replicated after AMP treatment represented a pep-
ide-resistant population, random plaques were selected
rom assay plates containing virus exposed to 100 mM
E2P and R2P and retested for peptide sensitivity. Virus
prepared from four plaques isolated after treatment with
E2P, and from a single plaque isolated after treatment
with R2P, was as sensitive to 100 mM peptide as the
original virus stock. This result suggests that the residual
infectivity seen after treatment with E2P or R2P is not due
to a minor population of genetically resistant virions, but
may be due to virus aggregation that prevents complete
virus inactivation.
To determine whether the treatment conditions used
above were optimal for virus inhibition, FV3 and CCV
were incubated with E2P and R2P for varying periods of
time (10–180 min) and over a temperature range of
0–26°C. In these studies, peptide concentrations were
chosen that resulted in an ;50–80% reduction in infec-
tivity. As shown in Fig. 2, incubation of FV3 with 50 mM
2P for 10 min at 26°C resulted in an ;80% reduction in
nfectivity. Incubation for an additional 50 or 170 min
esulted in at most a further twofold reduction in infec-
ivity. Approximately equal levels of inhibition were seen
ollowing treatment of FV3 with 50 mM R2P. Similar re-
sults were seen with CCV where 5 mM E2P reduced CCV
nfectivity by ;80% after 10 min and by ;90% after 180
in. Although in the experiment shown in Fig. 2 R2P
esulted in only a 40% reduction in titer, levels of inhibi-
ion similar to those seen with E2P were observed in
ther experiments. Taken together these results suggest
hat E2P and R2P acted rapidly and that most of their
ntiviral effect was determined within the first 10 min of
nteraction.
Because temperature influences the fluidity of mem-
ranes, the impact of temperature on inhibition was also
etermined. CCV was incubated with 12.5 mM E2P or
R2P for 1 h at 0, 18, and 26°C. As shown in Fig. 3A, a
marked drop in CCV infectivity was seen at all tempera-
tures. Similar results were seen with FV3 (Fig. 3B), indi-cating that viral inactivation occurred over a wide tem-
perature range (i.e., 0–26°C). While it is likely that inac-
tivation occurred at low temperatures it is also possible
that binding of the peptide to the virus took place rapidly
in the cold, but that inactivation occurred only later when
the virus was added to the cells and exposed to higher
temperatures.
To strengthen the suggestion that the peptides re-
duced viral infectivity by interacting directly with the
virion, rather than by influencing replicative events in
virus-infected cells, we determined whether pre- or post-
treatment of virus-infected cells with peptide blocked
infectivity. Accordingly, CCO cell monolayers were incu-
bated with 10 mM E2P or R2P either for 1 h before
addition of virus or 1 h after addition of virus. Although
this peptide concentration is lower than those used in
most of the experiments described above, it was chosen
because it is equivalent to the highest concentration of
peptide present when the diluted virus sample was
added to cell monolayers during a plaque assay. If the
peptide perturbs the cell membrane in a manner that
blocks virus entry, or if peptide–cell interaction triggers
events that inhibit virus replication, then treatment of
CCO cells prior to, or following, CCV adsorption should
result in a lower level of virus replication. As shown in
Table 2, pretreatment of cells prior to virus addition, or
posttreatment of cells following virus adsorption, had
only a minimal effect on virus infectivity, suggesting that
the peptides exerted their inhibitory effect on the virus
FIG. 2. Effect of increased incubation time on inactivation induced by
E2P and R2P. Ten-microliter aliquots of FV3 or CCV were incubated with
E2P or R2P and incubated at 26°C for the indicated periods of time.
Residual infectivity was determined, and the results are expressed
relative to the titer of virus incubated in the absence of peptide (shown
here as the 0-min time point). For FV3, treatment was with 50 mM E2P
or R2P; for CCV treatment was with 5 mM E2P or R2P. The data shown
epict a representative experiment.directly, perhaps by disrupting the viral envelope, rather
than by altering virus replication in the infected cell.
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354 CHINCHAR ET AL.Electron microscopy
To directly confirm the effect of E2P and R2P on viral
infectivity, CCV and FV3 were incubated with peptide as
described above and visualized by transmission electron
microscopy. In the presence of water alone (control),
numerous intact, enveloped CCV particles were ob-
served (Fig. 4). Following treatment of CCV with either 50
mM E2P or R2P, fewer particles, both total and intact,
were detected, suggesting that AMPs adversely affected
viral integrity. From these results it appears that the
AMPs lysed not only the viral envelope, but also affected
the stability of the nucleocapsid. In contrast to the
marked effect of E2P and R2P on CCV, treatment of FV3
with 500 mM E2P or R2P appeared to have no detectable
ffect on virion morphology or integrity. Although subtle
hanges in the appearance of treated FV3 virions were
oted, their significance was unclear since similar
hanges were also seen, albeit to a lesser extent, in
FIG. 3. Effect of temperature on peptide activity. Equal volumes of
irus and peptide were incubated for 1 h at the indicated temperatures
nd residual infectivity was determined. FV3 was incubated with 500
mM peptide, whereas CCV was incubated with peptide at a final
concentration of 12.5 mM. The data shown depict a representative
experiment.ontrol reactions (data not shown). Furthermore, .90%
f virions present within the FV3 preparation were non-nveloped, indicating that the sensitivity of these prepa-
ations to inactivation was not due to an increased num-
er of enveloped particles. These results are consistent
ith E2P and R2P interacting with, and disrupting, the
CV envelope and/or nucleocapsid and support the no-
ion that AMPs directly inactivate viral infectivity.
DISCUSSION
The results presented above demonstrate that E2P
nd R2P decrease FV3 and CCV infectivity. This is the
irst demonstration that amphibian skin peptides inacti-
ate physiologically relevant amphibian viral pathogens,
nd it is one of the few studies showing that AMPs
nactivate viruses. Our results are consistent with those
sing mammalian and amphibian AMPs to inactivate
ammalian viruses (Lehrer et al., 1985; Daher et al.,
1986; Egal et al., 1999; Yasin et al., 2000) and suggest that
these compounds may play a role in preventing viral
infections in amphibians. Moreover, in contrast to previ-
ous studies, we found that E2P and R2P were effective
against both enveloped and nonenveloped virions and
that they acted rapidly at both low and ambient temper-
atures.
As shown in Fig. 1, CCV is 10–20 times more sensitive
to peptide-induced inactivation than FV3. However, it is
not known whether the increased sensitivity of CCV to
E2P and R2P reflects inherent differences in the suscep-
tibility of the two viruses or is a reflection of the high
percentage of nonenveloped virions within the FV3 prep-
aration that may be less susceptible to an agent that
primarily disrupts biological membranes. It is estimated
that 80% of FV3 virions remain cell associated and are
likely nonenveloped (Braunwald et al., 1979; Goorha and
TABLE 2
Effect of Exposure to Peptide Pre- or Post-CCV Adsorption
Virus titer (percentage of control)
Agenta Treatment Experiment 1b Experiment 2 Expectedc
Water Pre- 100% 100% 100%
ater Post- 100% 100% —
2P Pre- 96% 89% 28%
2P Post- 78% 91% —
2P Pre- 95% n.d.d 43%
R2P Post- 68% n.d. —
a Cell monolayers grown on 35-mm dishes were incubated with 0.1
l of DMEM containing 4% FCS and 10 mM E2P or R2P for 1 h either
directly before (“pre-”) or immediately following (“post-”) virus adsorp-
tion. Monolayers were subsequently overlaid with DMEM containing
Noble’s agar and incubated for 7 days to allow plaque development.
b The values shown here are virus titers expressed as a percentage
of control (i.e., titer following incubation of virus with water alone).
c The value shown here is the expected titer following incubation of
virus and peptide for 1 h at 26°C.
d n.d. denotes “not determined.”
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355ANTIMICROBIAL PEPTIDES ISOLATED FROM FROG SKINGranoff, 1979). Thus the 90% reduction in FV3 plaque
formation seen after treatment with 500 mM E2P is
igher than expected if the peptide were acting only
gainst enveloped forms of the virus. In view of this, it is
ossible that E2P disrupts the internal lipid membrane
hat underlies the FV3 capsid (Willis and Granoff, 1974;
illiams et al., 2000). If this hypothesis is correct, the
igher susceptibility of CCV to peptide inhibitors may
eflect the ease with which its essential membrane (i.e.,
he viral envelope) is degraded. In contrast, the relative
esistance of FV3 may be due to the decreased acces-
ibility of the inner membrane of FV3 and other iridovi-
uses.
In support of the above hypothesis, several observa-
ions are relevant. First, Braunwald et al. (1985) specu-
ated that the inner membrane of FV3 is essential for
ntry by nonenveloped FV3 particles. Second, the inter-
al membrane is essential for infectivity since lipid sol-
ents render virions noninfectious (Willis and Granoff,
974). Third, Broo et al. (2001) showed that alkylating
gents were able to permeate the capsid of a nonenvel-
ped virus, flockhouse virus (FHV), and inactivate viral
ucleic acid. This finding is consistent with work by
othner et al. (1998) showing that internal regions of the
HV virion were readily susceptible to proteolytic degra-
ation. Taken together these results suggest that the
iral capsid is a dynamic structure in which internal
rotein regions can translocate to the capsid surface and
mall molecules can penetrate to the interior. If the same
henomena occur with FV3, then AMPs may be able to
enetrate the viral capsid and disrupt the internal mem-
rane. As suggested by the plaque reduction (Fig. 1) and
lectron microscopic data, this may result in a loss of
nfectivity, without an overt change in virion morphology.
Additional experiments, in which peptide was added
o cells 1 h before infection, or 1 h after infection, also
upport the view that E2P and R2P function by directly
nactivating virions. If the peptides acted by altering host
FIG. 4. Transmission electron microscopy of control and peptide-trea
ere visualized by transmission electron microscopy as described unell membranes and disrupting virus entry or subsequent
eplicative events, or if the peptides acted by perturbing
e
dvents in virus-infected cells and blocking one or more
unctions essential for virus replication, then AMPs
dded directly to the cells should be as inhibitory as
MPs present in the virus plus peptide mixture. The
bservation that the latter are more inhibitory than the
ormer suggests that peptide–virus interaction leads to
irect inactivation of virus infectivity. This result is con-
istent with findings in a related system, wherein the
efensin HNP-1 was shown to directly bind HSV-1 (Daher
t al., 1986). Electron microscopic investigation of pep-
ide-treated virions supports this view and shows degra-
ation of the CCV envelope following peptide treatment.
n contrast there were only minor changes in FV3 mor-
hology after peptide treatment, suggesting that if pep-
ides disrupted the internal FV3 membrane, its dissolu-
ion did not adversely affect virion morphology. Similar to
he assembly of African swine fever virus capsids, it is
ossible that the internal membrane of FV3 serves as a
caffold, or nucleation point, for capsid formation (An-
res et al., 1998). Alternatively, lipid and capsid protein
nteraction may result in the formation of complexes that
elf-assemble around viral DNA cores and produce ma-
ure FV3 virions (Willis and Granoff, 1974). Thus disrup-
ion of the internal membrane within mature virions may
ot markedly affect virion morphology, but may decrease
irion infectivity.
In contrast to results with MCP-1 and MCP-2 (Lehrer et
l., 1985), two peptides isolated from rabbit granulocytes
nd alveolar macrophages, and HNP-1, a defensin iso-
ated from human neutrophils (Daher et al., 1986), we did
ot observe a marked decrease in viral infectivity with
ncreased incubation time, nor did we see enhanced
irus inactivation at higher temperatures (Figs. 2 and 3).
t present it is not known whether this reflects differ-
nces in the peptides (i.e., defensin family vs esculentin/
anatuerin family) or in the target viruses. However, since
2P and R2P function in amphibians, it would not be
urprising if they retain activity at low temperatures. For
V. CCV was incubated for 1 h at 26°C in 50 mM E2P or R2P, and virions
terials and Methods. Magnification, 45,0003.xample, since amphibians are often at risk of infection
uring spring spawning, it would be reasonable that
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356 CHINCHAR ET AL.antimicrobial peptides maintain activity at temperatures
lower than those optimal for mammalian-derived pep-
tides.
Coupled with previous work, the current study indi-
cates that E2P and R2P inactivated both enveloped and
nonenveloped viral pathogens in vitro. In the wild,
quatic animals are exposed to infectious agents by
ngestion, respiration, and/or skin contact. Whether anti-
icrobial peptides, either induced or constitutively
resent, are sufficient to block infectivity on mucosal and
kin surfaces, and thus influence the outcome of infec-
ion, remains to be determined. Tyler et al. (1992) showed
that mild electrical stimulation, or treatment with adren-
ergic agents, led to the release of ;50 mg of peptides
from the skin of frogs. While these agents may be rapidly
diluted in the surrounding aquatic environment, it is pos-
sible that their effective concentration on the surface of
the skin or on mucosal membranes may be sufficient to
inactivate pathogenic organisms. Furthermore, it is not
clear whether environmental insults (e.g., spawning
stress, pollutants, UV irradiation, crowding) lower the
level of antimicrobial peptides and thus increase sus-
ceptibility to certain pathogens. For example, FV3 has
been viewed as a relatively nonpathogenic virus in wild
R. pipiens (Goorha and Granoff, 1978). However, die-offs,
ttributable to an FV3-like virus, have recently occurred
mong cultured frogs (R. grylio and R. tigrina) in China
and Thailand (Kanchanakhan, 1998; Zhang et al., in
press), suggesting that an agent of low pathogenicity in
healthy animals can trigger high levels of morbidity and
mortality in “stressed” animals. Clearly, elucidating inter-
actions among hosts, pathogens, peptides, and environ-
ment will be required to determine the role of AMPs in
disease prevention.
MATERIALS AND METHODS
Cells and virus
FV3, originally obtained from Allan Granoff, St. Jude
Children’s Research Hospital (Memphis, TN), was
propagated in FHM cells grown in sealed 175-cm2
tissue culture flasks at 26°C in Eagle’s minimum es-
sential medium containing Hank’s salts (HMEM) and
2–4% fetal calf serum (FCS). CCV (ictalurid herpesvirus
1) was purchased from the American Type Culture
Collection (VR-665) and grown in CCO cells in closed
flasks at 26°C using Dulbecco’s modified Eagle’s me-
dium (DMEM) with 4% FCS. For plaque assay, both
FHM and CCO cells were grown at 26°C in a humid-
ified CO2 incubator using DMEM with 4% FCS. FHM
ells were purchased from the American Type Culture
ollection (CCL-42); CCO cells were obtained from Dr.
. Hanson, Mississippi State University, College of
eterinary Medicine.eptides
The inhibitors E2P and R2P (Table 1) were originally
solated from the skin of R. pipiens (Goraya et al., 2000).
he peptides used in this study were commercially syn-
hesized (Sigma/Genosys, Woodland, TX), dissolved in
terile water at a concentration of 1 mM, and stored at
70°C until use (Rollins-Smith et al., in press).
laque inhibition assay
To determine whether E2P and R2P inactivated FV3
nd CCV, plaque reduction assays were performed.
riefly, 10 ml of either FV3 or CCV (containing between
106 and 108 PFU/ml) was mixed with either 10 ml peptide
at the indicated concentration or 10 ml sterile deionized
water (control) and incubated at 26°C. After 1 h, samples
were diluted with 1 ml of DMEM containing 4% FCS.
Subsequently, samples were serially diluted 10-fold in
DMEM/4% FCS, and 0.1-ml volumes of the appropriate
dilutions were plated in duplicate onto FHM (for FV3) or
CCO (for CCV) monolayers grown on 35-mm tissue cul-
ture dishes or 6-well tissue culture plates. Following 1 h
of incubation at 26°C to permit virus adsorption, the
monolayers were overlaid with DMEM containing 2%
FCS and 1% Noble’s agar and incubated for 5–7 days at
26°C. At that time, the cultures were stained with 2.5 ml
of DMEM containing neutral red and incubated at 26°C
for at least 6 h, and the plaques were counted. In some
experiments involving FV3, residual infectivity was deter-
mined by a TCID50 assay rather than by plaque assay.
Transmission electron microscopy
Equal volumes of virus and peptide were mixed, incu-
bated at 26°C for 1 h, and visualized by transmission
electron microscopy. FV3 was exposed to 500 mM E2P or
2P; CCV was treated with 50 mM E2P or R2P. Treated
irus preparations were adsorbed to freshly glow-dis-
harged, carbon-coated grids, negatively stained with 2%
hosphotungstic acid, and observed in a Phillips 301
lectron microscope at 60 kV (Coronell et al., 1999).
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